Synthesis of the orally active spiroindoline-based growth hormone secretagogue, MK-677
1997
Abstract The preparation of the Merck Growth Hormone Secretagogue; MK-677 is described. A Fischer indole/reduction based strategy provides the novel spiroindoline nucleus of this potent compound. This optimized sequence necessitates the isolation of only one intermediate 10 and provides MK-677 in 48% overall yield from isonipecotic acid 3 .
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
40
Citations
NaN
KQI